Acute Myeloid Leukaemia (AML)
Conditions
Interventions
Patient education and training to perform self-measurement of lung capacity and mechanical lung traning with Positive Expiratory Pressure (PEP).
Patients are included when diagnosed with AML and che
Sponsors
Lundbeck Foundation (Denmark)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients (>18 years) with Acute Myeloid Leukaemia (AML) and Myelodysplatic Syndrome demanding intensive intravenous chemotherapy and diagnosed at the Copenhagen University Hospitales Rigshospitalet and Herlev Hospital.
Exclusion criteria
Exclusion criteria: 1. non-Danish speaking 2. Psychotic patients 3. Patients requiring care in Intensive Care Units (ICUs)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Incidence of X-ray verified lung infiltrates during the 3 month follow up period 2. Forced Expiratory Volume in 1 second (FEV1) as predictive diagnostic tool for pneumonia | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Quality of Life (QOL) - EORTC-QLQ-C30 2. SF36 short form 3. Hospital Anxiety Depression (HAD) 4. Self-efficacy 5. Coping - Mini Mental Adjustment to Cancer (Mini-MAC) Above outcomes measured at baseline and at 3 month follow up 6. Qualitative findings derived from semi-structured interviews conducted at the end of 3 month follow up. | — |
Countries
Denmark
Outcome results
None listed